SALVAGE THERAPY IN RECURRENT GERM-CELL CANCER - IFOSFAMIDE AND CISPLATIN PLUS EITHER VINBLASTINE OR ETOPOSIDE

被引：233

作者：

LOEHRER, PJ ^{[1
]}

LAUER, R ^{[1
]}

ROTH, BJ ^{[1
]}

WILLIAMS, SD ^{[1
]}

KALASINSKI, LA ^{[1
]}

EINHORN, LH ^{[1
]}

机构：

[1] INDIANA UNIV, SCH MED, INDIANAPOLIS, IN 46202 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1988年 / 109卷 / 07期

关键词：

D O I：

10.7326/0003-4819-109-7-540

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：540 / 546

页数：7

共 30 条

[1]

AIGINGER P, 1982, 13TH P INT CANC C SE, V13, P180

[2] ROLE OF ETOPOSIDE-BASED CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH REFRACTORY OR RELAPSING GERM-CELL TUMORS [J].

BOSL, GJ ;

YAGODA, A ;

GOLBEY, RB ;

WHITMORE, W ;

HERR, H ;

SOGANI, P ;

MORSE, M ;

VOGELZANG, N ;

MACDONALD, G .

AMERICAN JOURNAL OF MEDICINE, 1985, 78 (03) :423-428

[3]

BOUTIS LL, 1982, 13TH P INT CANC C SE, V13, P181

[4] CYCLOPHOSPHAMIDE VERSUS IFOSFAMIDE - FINAL REPORT OF A RANDOMIZED PHASE-II TRIAL IN ADULT SOFT-TISSUE SARCOMAS [J].

BRAMWELL, VHC ;

MOURIDSEN, HT ;

SANTORO, A ;

BLACKLEDGE, G ;

SOMERS, R ;

VERWEY, J ;

DOMBERNOWSKY, P ;

ONSRUD, M ;

THOMAS, D ;

SYLVESTER, R ;

VANOOSTEROM, A .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (03) :311-321

[5]

BRESLOW NE, 1980, IARC SCI PUBL, V32, P192

[6] THE OXAZAPHOSPHORINES [J].

BROCK, N .

CANCER TREATMENT REVIEWS, 1983, 10 :3-15

[7] PHARMACOKINETICS AND MECHANISM OF ACTION OF DETOXIFYING LOW-MOLECULAR-WEIGHT THIOLS [J].

BROCK, N ;

HILGARD, P ;

POHL, J ;

ORMSTAD, K ;

ORRENIUS, S .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1984, 108 (01) :87-97

[8] A CONFIDENCE-INTERVAL FOR THE MEDIAN SURVIVAL-TIME [J].

BROOKMEYER, R ;

CROWLEY, J .

BIOMETRICS, 1982, 38 (01) :29-41

[9]

BUCKNER CD, 1974, CANCER CHEMOTH REP 1, V58, P709

[10]

COHEN MH, 1975, CANCER CHEMOTH REP 1, V59, P751

← 1 2 3 →